Incannex Healthcare Inc (NASDAQ:IXHL)’s traded shares stood at 17.23 million during the last session, with the company’s beta value hitting 2.48. At the close of trading, the stock’s price was $0.20, to imply a decrease of -10.62% or -$0.03 in intraday trading. The IXHL share’s 52-week high remains $3.55, putting it -1675.0% down since that peak but still an impressive 60.0% since price per share fell to its 52-week low of $0.08.

Incannex Healthcare Inc (NASDAQ:IXHL) trade information

After registering a -10.62% downside in the last session, Incannex Healthcare Inc (IXHL) has traded red over the past five days. The 5-day price performance for the stock is -24.77%, and -65.76% over 30 days. With these gigs, the year-to-date price performance is -90.47%.

Revenue forecast for the current quarter as set by 1 analysts is 157k. Meanwhile, for the current quarter, a total of 1 analyst(s) estimate revenue growth to 157k.

IXHL Dividends

Incannex Healthcare Inc has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

We also have AdvisorShares Trust-AdvisorShares Psychedelics ETF and Bridgeway Funds, Inc.-Ultra-Small Company Market Fund as the top two Mutual Funds with the largest holdings of the Incannex Healthcare Inc (IXHL) shares. Going by data provided on Apr 30, 2025 , AdvisorShares Trust-AdvisorShares Psychedelics ETF holds roughly 343.95 shares. This is just over 1.17% of the total shares, with a market valuation of $69478.0. Data from the same date shows that the other fund manager holds a little less at 25.0, or 0.08% of the shares, all valued at about 5050.0.